COVID-19 pandemic has created new problems and compounded existing ones faced by the global clinical research community. Without physical access to patients, the impact on data collection and patient monitoring has been significant and has forced an industry-wide initiative to re-evaluate how to manage clinical trials in this new paradigm.
In a recent industry survey, Oracle Health Sciences, in partnership with Informa Research, sought to gather insight on the impact of the Covid-19 pandemic on clinical data collection and clinical operations.
This webinar will provide perspectives from a leading CRO in Europe, about the obscurity around the implementation of new regulations, and how they are dealing with this new paradigm. Through the market research you will gain insight into the rate of adoption to decentralized trials, the need for new collaborations, and what new strategies are being assessed to overcome and flourish in this new world.
Presented by
Jim Streeter,
Global Vice President, Life Sciences Product Strategy, Oracle Health Sciences
As the global head of life sciences product strategy for Oracle, James Streeter collaborates closely with Oracle customers, regulatory agencies, analysts, and industry thought leaders to develop and help execute the overall business and product strategy for Oracle Health Sciences. He previously held leadership roles at PPD in both operations, as the Global Head of Global Clinical Technical Operations and EDC and recently in IT, as Global Head of Systems Development, Business Operations Teams, and eClinical Strategy and Innovation.
James has 25 years of data acquisition and analysis experience utilizing computerized systems and has focused on eClinical systems and processes for trials for the last 15 years. James’ experience includes implementing end to end eClinical Solutions and processes across all therapeutic areas and all phases of studies.
James’ early experience in eClinical was gained at Pfizer Inc., where he was Senior Director of Global Clinical Data Services, heading the global data acquisition department for the company’s global research and development organization. Prior to joining Pfizer, he was a Senior Hardware, Software and Systems Engineer for the U.S. Navy Underwater Sound Laboratory with a focus in data acquisition and analysis.
Julia Lakeland,
Scientific Data Solutions Architect and Program Director
Julia is a Solutions Architect and Program Director at Parexel who is passionate about improving the patient experience within the clinical trial. She has 20 years’ experience in industry and plays a key role leading our Parexel patient sensors solution in selecting and implementing real-world data solutions, wearables and connected devices for clinical trial use. Julia has a background in product management, operational delivery and support of global Phase 3 and 4 clinical trials using a multitude of clinical technology solutions including IRT, EDC, CTMS, eCOA, logistics, digitalization and wearable sensors across a wide range of therapeutic areas.
Rosamund Round,
Vice President, Patient Innovation Center and Decentralized Trials at Parexel
Experienced and passionate innovation and patient centricity professional, leading Parexel’s Patient Innovation Center. This includes decentralized clinical trials and patient engagement activities to enhance experiences in clinical research.
